ETFChannel.com
EXAS Description — EXACT Sciences Corp.

Exact Sciences is a molecular diagnostics company, focused on the early detection and prevention of cancer. Co. has developed a non-invasive screening test called Cologuard® for the early detection of colorectal cancer and pre-cancer. Co.'s Cologuard test is a non-invasive stool-based DNAscreening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co. is also working on the development of additional tests for other types of cancer. Co. is also focusing its research and development efforts on building a pipeline of potential future products and services with a focus on blood-based tests.

Company Name: 
EXACT Sciences Corp.
Website: 
www.exactsciences.com
Sector: 
Biotechnology
Number of ETFs Holding EXAS: 
40
Total Market Value Held by ETFs: 
$1,386,016,428
Total Market Capitalization: 
$12,101,000,000
% of Market Cap. Held by ETFs: 
11.45%
 ETF   EXAS Weight   EXAS Amount 
 VTI   0.04%   $356,822,396         
 VO   0.30%   $313,434,089         
 VXF   0.24%   $164,922,574         
 VUG   0.09%   $92,286,788         
 VOT   0.55%   $84,196,224         
 XBI   1.46%   $76,745,222         
 FBT   3.46%   $70,931,914         
 IWP   0.36%   $42,922,742         
 IWF   0.07%   $38,078,732         
 IWR   0.16%   $31,672,047         
List of all 40 ETFs holding EXAS »
Quotes delayed 20 minutes

Strong Buy (3.93 out of 4)
79th percentile
(ranked higher than approx. 79% of all stocks covered)

Analysts Forecast:
EXAS Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding EXAS | EXACT Sciences Corp. | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2020, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.